MongoDB arrives at its May 28 earnings report having recovered sharply from a brutal February, and the question now is whether the positioning around that rally makes sense.
The stock is up 27% over the past month and 8.4% on the week, closing at $334.68. That move has dragged short sellers along with it — but they haven't capitulated. Options traders, meanwhile, have swung from complacency to outright defensiveness in the span of a few days.
The most striking signal this week is in the options market. Put demand has surged dramatically ahead of earnings, with the put/call ratio jumping to 0.82 on Tuesday — more than three standard deviations above its 20-day average of 0.57. That's the most defensive options read in months, and it arrived precisely as the stock pushed to its highest levels since early in the year. Traders running up the stock with one hand appear to be buying insurance with the other.
Short positioning tells a complementary but distinct story. SI has climbed to 4.5% of the free float — up roughly 18% over the past month — as new shorts have pressed into the rally rather than been flushed out by it. The move from around 3.7% in mid-April to 4.5% today is gradual but consistent: short sellers have been building every week even as the price rose $85 from its April lows. Borrow conditions offer them no friction; availability is extraordinarily loose at roughly 4,800% of short interest, and cost to borrow has actually fallen 15% on the week to just 0.34% annually. With shares this cheap to borrow and this easy to find, the short build looks like conviction rather than technical pressure.
The Street's view is divided but tilting positive. Most recent analyst actions have been target raises: Citigroup lifted to $450 this month while keeping a Buy, BMO Capital moved to $360 from $285, and Baird nudged to $335 from $260 — though the latter maintained a Neutral. RBC reiterated its Outperform at $395. The mean target across the coverage universe is $358.82, implying modest upside from current levels. Bulls point to MongoDB's growing share of PostgreSQL migrations, a developer community aligned with AI-native workloads, and improving enterprise discipline since recent leadership changes. Bears counter that competition is intensifying and that AI tailwinds have yet to translate into the consumption-led revenue inflection the stock's multiple demands. At a forward P/E of 53 and a P/B ratio that has expanded by 1.45 turns over the past month, the valuation reflects considerable optimism. Growth scores from ORTEX rank in the 61st percentile — solid but not exceptional — while the value score has drifted lower, now in the 18th percentile.
On the ownership side, founder Dwight Merriman has been selling into the rally. He offloaded shares across multiple tranches on May 14 and May 18, with the combined value over those two days running to roughly $2.6 million. The significance scores on each transaction are low, and Merriman remains the seventh-largest reported holder with around 1.48 million shares, so the sales look like routine diversification rather than a directional signal. Institutional ownership remains anchored by Vanguard at 10.8% and BlackRock at 7.1%, with T. Rowe Price adding 317,000 shares in the most recent quarter.
The earnings reaction history adds context without comfort. The most recent print — March 2026 — saw the stock fall 23% the following day and 17% over the subsequent five days, one of the largest post-earnings drops in MongoDB's recent history. The prior release produced a 9% gain. That binary pattern, combined with a 27% run into the event, is exactly the setup options traders appear to be pricing. With the report due on May 28, the tension between an improving growth narrative and a premium valuation — tested by a stock that has recently moved violently in both directions on results day — is what to watch.
See the live data behind this article on ORTEX.
Open MDB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
